EUVIMEDEUVIMED entdecken
Crossref

Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?

Karla Hemming, Stephan D Fihn

JAMA Network Open · 03.11.2026 · 9 (11) · e2640988

DOI: 10.1001/jamanetworkopen.2026.40988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 03.11.2026. Verfasst von Karla Hemming und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Statistical Editor, JAMA Network Open.
  • Department of Medicine, University of Washington, Seattle.
  • Executive Deputy Director, JAMA Network Open.

Zitieren

APA

Hemming, K., & Fihn, S. D. (2026). Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?. JAMA Network Open, 9(11), e2640988. https://doi.org/10.1001/jamanetworkopen.2026.40988

Vancouver

Hemming K, Fihn SD. Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?. JAMA Network Open. 2026;9(11):e2640988. doi:10.1001/jamanetworkopen.2026.40988

BibTeX
@article{Hemming2026,
  author = {Hemming, Karla and Fihn, Stephan D},
  title = {Beyond Statistical Significance—What Did EMERGE Really Tell Us About Early Metformin?},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {e2640988},
  doi = {10.1001/jamanetworkopen.2026.40988}
}
Kostenlos starten →